Market Overview

Wedbush Reduces PT to $60 on Pall Corporation Due to Outlook

Share:
Related PLL
Benzinga's Volume Movers
Morning Market Gainers
PRIMECAP Sells Stake in Biopharmaceutical Company (GuruFocus)

Wedbush reiterates its Neutral rating on Pall Corporation (NYSE: PLL) but cuts its price target from $64 to $60.

Wedbush says, "The disappointing quarter underscores the structural work ahead for Pall's new management, while global uncertainty creates some headwinds. Although adjusted earnings from continuing operations of $0.61 were $0.09 below our estimate, we believe the longterm fundamentals of PLL's business are healthy, while the next six months are likely to be below prior expectations."

PLL closed at $52.35 on Monday.

Latest Ratings for PLL

DateFirmActionFromTo
May 2015BairdDowngradesOutperformNeutral
May 2015William BlairDowngradesOutperformMarket Perform
May 2015BB&T CapitalDowngradesHoldUnderweight

View More Analyst Ratings for PLL
View the Latest Analyst Ratings

Posted-In: WedbushAnalyst Color Price Target Reiteration Intraday Update Analyst Ratings

 

Related Articles (PLL)

Get Benzinga's Newsletters